Community-acquired pneumonia. Clinical recommendations. Yesterday, today and tomorrow. To the article (round-table discussion: physician, pulmonologist, clinical pharmacologist)

• Main Authors: Leonid I. Dvoretsky, Sergei V. Iakovlev, Mariia A. Karnaushkina
• Format: Article
• Language: Russian
• Published: ZAO "Consilium Medicum" 2019-03-01
• Series: Consilium Medicum
• Subjects: community-acquired pneumonia; antimicrobial therapy; antimicrobial drug; antibiotic resistance
• Online Access: http://consilium.orscience.ru/en/archive/2019/vol-21-3-2019/community-acquired-pneumonia-clinical-recommendations-yesterday-today-and-tomorrow-to-the-article-ro_5489/?element

Diagnostics and antimicrobial therapy of community-acquired pneumonia are discussed considering updated clinical recommendations. Diagnostic implications of clinical symptoms and radiologic investigation results are evaluated. Special attention is given to the choice of the first antimicrobial drug with regard to approximate etiological cause of pneumonia, disease severity, antibiotic resistance risk, and antimicrobial drug pharmacological properties. Evaluation of antimicrobial drug effectiveness and decision for future management tactics in case of its ineffectiveness as well as antimicrobial therapy duration are important practical aspects of patient management. Importance of present and future clinical recommendations for medical practitioners is emphasized.